Gene · 5606
Papers2,515
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,515
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dapagliflozin attenuates nicotine-induced apoptosis by targeting the ASK1/p38/JNK apoptotic pathway in HK-2 cells. | Sci Prog | 2025 | 40820478 | PubTator, text mining | PubMed |
| scCOSMIX: A Mixed-Effects Framework for Differential Coexpression and Transcriptional Interactions Modeling in Single-Cell RNA-Seq. | Stat Med | 2025 | 40772737 | PubTator, text mining | PubMed |
| The prognostic value of mitogen-activated protein kinase kinase in liver hepatocellular carcinoma by bioinformatics. | Medicine (Baltimore) | 2025 | 40587753 | PubTator, text mining | PubMed |
| Integrating network toxicology, transcriptomics, and metabolomics uncovers the hepatotoxic mechanisms of okadaic acid in LO2 cells. | Ecotoxicol Environ Saf | 2025 | 40561608 | PubTator, text mining | PubMed |
| Antitumor effects of plasma-activated sodium acetate solution on gastric cancer cells. | Sci Rep | 2025 | 40473706 | PubTator, text mining | PubMed |
Corrigendum to "PKC-δ and -η, MEKK-1, MEK-6, MEK-3, and p38-δ Are Essential Mediators of the Response of Normal Human Epidermal Keratinocytes to Differentiating Agents" [Journal of Investigative Dermatology, Volume 130, Issue 8, August 2010, Pages 2017-2030]. | J Invest Dermatol | 2025 | 40252056 | PubTator, text mining | PubMed |
| The Application of Non-Coding RNAs as Biomarkers, Therapies, and Novel Vaccines in Diseases. | Int J Mol Sci | 2025 | 40243658 | PubTator, text mining | PubMed |
| Employing steered MD simulations for effective virtual screening: Active pharmacophore search by dynamic corrections to target MKK3-MYC interactions. | Int J Biol Macromol | 2025 | 40157686 | PubTator, text mining | PubMed |
| Proteomic insights into the molecular mechanism of anlotinib inhibition in TP53-mutated non-small cell lung cancer. | J Proteomics | 2025 | 40113013 | PubTator, text mining | PubMed |
| Identifcation of the FGF family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma. | SLAS Technol | 2025 | 40086631 | PubTator, text mining | PubMed |
| Role of the ETV5/p38 signaling axis in aggressive thyroid cancer cells. | bioRxiv | 2025 | 40027641 | PubTator, text mining | PubMed |
| Comprehensive characterization of pathogenic missense CTRP6 variants and their association with cancer. | BMC Cancer | 2025 | 39979869 | PubTator, text mining | PubMed |
| Identification of sinensetin as a selective inhibitor for mitogen-activated protein kinase kinase 6 and an anticancer agent for non-small cell lung cancer. | Am J Cancer Res | 2025 | 39949939 | PubTator, text mining | PubMed |
| Retraction Note: Elevation of miR-21, through targeting MKK3, may be involved in ischemia pretreatment protection from ischemia-reperfusion induced kidney injury. | J Nephrol | 2025 | 39894888 | PubTator, text mining | PubMed |
| Phospholipase C β4 promotes RANKL-dependent osteoclastogenesis by interacting with MKK3 and p38 MAPK. | Exp Mol Med | 2025 | 39894822 | PubTator, text mining | PubMed |
| Covalent Plant Natural Product that Potentiates Antitumor Immunity. | J Am Chem Soc | 2025 | 39794153 | PubTator, text mining | PubMed |
| Nanodomain cAMP signaling in cardiac pathophysiology: potential for developing targeted therapeutic interventions. | Physiol Rev | 2025 | 39115424 | PubTator, text mining | PubMed |
| MicroRNA Nobel Prize: Timely Recognition and High Anticipation of Future Products-A Prospective Analysis. | Int J Mol Sci | 2024 | 39684593 | PubTator, text mining | PubMed |
| Current Insights into Weak Seed Dormancy and Pre-Harvest Sprouting in Crop Species. | Plants (Basel) | 2024 | 39339534 | PubTator, text mining | PubMed |
| Circulating free heme induces cytokine storm and pulmonary hypertension through the MKK3/p38 axis. | Am J Physiol Lung Cell Mol Physiol | 2024 | 39197168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5606/papers?page=3